COMPASS PATHWAYS PLC (CMPS)

US20451W1018 - ADR

4.45  -0.21 (-4.51%)

After market: 4.4063 -0.04 (-0.98%)

News Image
6 days ago - Investor's Business Daily

Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS

President-elect Donald Trump tapped widely known vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.

News Image
8 days ago - Compass Pathways

Compass Pathways to participate in Stifel 2024 Healthcare Conference

LONDON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to...

News Image
21 days ago - The Motley Fool

Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript

CMPS earnings call for the period ending September 30, 2024.

News Image
2 months ago - Market News Video

COMPASS Pathways is Now Oversold (CMPS)

News Image
3 months ago - Compass Pathways

Compass Pathways to participate in three investor conferences in September

LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to...

News Image
3 months ago - Market News Video

Interesting CMPS Call Options For April 2025

News Image
4 months ago - The Motley Fool

Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript

CMPS earnings call for the period ending June 30, 2024.

News Image
4 months ago - Compass Pathways

Compass Pathways announces second quarter 2024 financial results and business highlights

Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression expected in fourth quarter 2024 Gino Santini to join...

News Image
4 months ago - Compass Pathways

Compass Pathways to announce second quarter financial results on August 1, 2024

LONDON, July 24, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to...

News Image
4 months ago - InvestorPlace

3 Dirt-Cheap Drug Developers With Blockbuster Potential

These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent.